diphosphoric acid has been researched along with Cardiomyopathies, Primary in 25 studies
diphosphoric acid : An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tafamidis has been used for treatment of transthyretin cardiac amyloidosis (ATTR-CA)." | 8.31 | Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis. ( Chang, CY; Hu, LH; Huang, WS; Lee, TH; Peng, NJ; Wang, YF, 2023) |
| "Tafamidis has been used for treatment of transthyretin cardiac amyloidosis (ATTR-CA)." | 4.31 | Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis. ( Chang, CY; Hu, LH; Huang, WS; Lee, TH; Peng, NJ; Wang, YF, 2023) |
| "Technetium-labeled bone-avid radiotracers can be used to diagnose transthyretin cardiac amyloidosis (ATTR-CA)." | 4.31 | Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. ( Chan, N; Cuomo, M; De Los Santos, J; DeLuca, A; Einstein, AJ; Fine, D; Griffin, JM; Helmke, S; Johnson, LL; Kinkhabwala, MP; Leb, JS; Maurer, MS; Miller, EJ; Mintz, A; Muralidhar, V; Pandey, S; Rosenblum, H; Ruberg, FL; Sabogal, N; Saith, SE; Smiley, D; Teruya, S; Winburn, M, 2023) |
| "Technetium-99mm pyrophosphate (Tc-PYP) scintigraphy is a highly accurate non-invasive method for the diagnosis of transthyretin (ATTR) cardiac amyloidosis." | 4.31 | A case of disappearing amyloid on technetium pyrophosphate scan. ( Jain, D; Mahmood, U; Pan, S; Tang, X; Wang, A, 2023) |
| "The article summarizes the current experience of the nuclear medicine department of the Chazov National Medical Research Center of Cardiology in the implementation of myocardium scintigraphy with 99mTc-pyrophosphate with the differential diagnosis of the types of cardiac amyloidosis." | 4.12 | [Myocardial scintigraphy with ( Ansheles, AA; Nasonova, SN; Saidova, MA; Sergienko, VB; Stukalova, OV; Tereshchenko, SN; Zhirov, IV, 2022) |
| "Pyrophosphate (PYP) imaging has a high diagnostic accuracy for transthyretin cardiac amyloidosis (ATTR-CA)." | 1.91 | Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy. ( Asif, T; Gupta, A; Malhotra, S; Murthi, M; Singh, V; Soman, P, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 25 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roshankar, G | 1 |
| White, GC | 1 |
| Cadet, S | 2 |
| Fine, NM | 2 |
| Chan, D | 2 |
| White, JA | 1 |
| Jimenez-Zepeda, V | 1 |
| Slomka, PJ | 2 |
| Miller, RJH | 2 |
| Watanabe, S | 1 |
| Nakajima, K | 1 |
| Wakabayashi, H | 1 |
| Yoneyama, H | 1 |
| Yoshida, S | 1 |
| Komatsu, J | 1 |
| Konishi, T | 1 |
| Inaki, A | 1 |
| Kinuya, S | 1 |
| Asif, T | 1 |
| Gupta, A | 1 |
| Murthi, M | 1 |
| Soman, P | 1 |
| Singh, V | 2 |
| Malhotra, S | 1 |
| Miller, EJ | 3 |
| Campisi, R | 1 |
| Shah, NR | 1 |
| McMahon, S | 1 |
| Cuddy, S | 1 |
| Gallegos-Kattan, C | 1 |
| Maurer, MS | 5 |
| Damy, T | 1 |
| Slart, RHJA | 1 |
| Bhatia, K | 3 |
| Einstein, AJ | 5 |
| Martyn, T | 1 |
| Saef, J | 1 |
| Hussain, M | 1 |
| Ives, L | 1 |
| Kiang, A | 1 |
| Estep, JD | 1 |
| Collier, P | 1 |
| Starling, RC | 1 |
| Cremer, PC | 1 |
| Tang, WHW | 1 |
| Hanna, M | 1 |
| Jaber, WA | 1 |
| Ge, Y | 1 |
| Pandya, A | 1 |
| Cuddy, SAM | 2 |
| Singh, A | 2 |
| Dorbala, S | 2 |
| Wlodarski, R | 1 |
| Seibert, K | 1 |
| Issa, NP | 1 |
| O'Brien-Penney, B | 1 |
| Soliven, B | 1 |
| Sarswat, N | 1 |
| Appelbaum, D | 1 |
| Rezania, K | 1 |
| Ansheles, AA | 1 |
| Nasonova, SN | 1 |
| Zhirov, IV | 1 |
| Saidova, MA | 1 |
| Stukalova, OV | 1 |
| Tereshchenko, SN | 1 |
| Sergienko, VB | 1 |
| Nichols, KJ | 1 |
| Yoon, SY | 1 |
| Van Tosh, A | 1 |
| Palestro, CJ | 1 |
| Saitou, T | 1 |
| Aikawa, T | 1 |
| Manabe, O | 1 |
| Nagase, A | 1 |
| Kudo, T | 1 |
| Oyama-Manabe, N | 1 |
| Khor, YM | 1 |
| Falk, RH | 1 |
| Di Carli, MF | 1 |
| Okada, A | 1 |
| Tateishi, E | 1 |
| Morita, Y | 1 |
| Ohta-Ogo, K | 1 |
| Izumi, C | 1 |
| Shen, CP | 1 |
| Vanichsarn, CT | 1 |
| Pandey, AC | 1 |
| Billick, K | 1 |
| Rubenson, DS | 1 |
| Mohan, RC | 1 |
| Heywood, JT | 1 |
| Srivastava, AV | 1 |
| Mori, A | 1 |
| Saito, Y | 1 |
| Nakamura, K | 1 |
| Iida, T | 1 |
| Akagi, S | 1 |
| Yoshida, M | 1 |
| Taniyama, M | 1 |
| Miyoshi, T | 1 |
| Ito, H | 1 |
| Pandey, S | 2 |
| Teruya, S | 2 |
| Rodriguez, C | 1 |
| Deluca, A | 2 |
| Kinkhabwala, M | 1 |
| Johnson, LL | 2 |
| Fine, D | 2 |
| Sabogal, N | 2 |
| Winburn, M | 2 |
| Castillo, M | 1 |
| Malkovskaya, R | 1 |
| Raiszadeh, F | 1 |
| Kurian, D | 1 |
| Ruberg, FL | 2 |
| Yu, AL | 1 |
| Chen, YC | 1 |
| Tsai, CH | 1 |
| Chao, CC | 1 |
| Su, MY | 1 |
| Juang, JJ | 1 |
| Lee, MJ | 1 |
| Hsieh, ST | 1 |
| Cheng, MF | 1 |
| Lin, YH | 1 |
| Lee, TH | 1 |
| Wang, YF | 2 |
| Hu, LH | 2 |
| Peng, NJ | 1 |
| Chang, CY | 1 |
| Huang, WS | 2 |
| Smiley, D | 2 |
| Chan, N | 3 |
| Mintz, A | 3 |
| Santana, DD | 2 |
| Shetty, M | 2 |
| Sekulic, M | 1 |
| Goldner, K | 2 |
| Wall, J | 1 |
| Helmke, S | 2 |
| Jerome, S | 1 |
| Farrell, MB | 1 |
| Warren, J | 1 |
| Embry-Dierson, M | 1 |
| Schockling, EJ | 1 |
| Griffin, JM | 1 |
| Rosenblum, H | 1 |
| Cuomo, M | 1 |
| De Los Santos, J | 1 |
| Kinkhabwala, MP | 1 |
| Leb, JS | 1 |
| Muralidhar, V | 1 |
| Saith, SE | 1 |
| Smiley, DA | 1 |
| Helmke, ST | 1 |
| Brannagan, TH | 1 |
| Wang, A | 1 |
| Mahmood, U | 1 |
| Tang, X | 1 |
| Jain, D | 1 |
| Pan, S | 1 |
| Kuo, Y | 1 |
| Chang, FP | 1 |
| Wang, WT | 1 |
| Yang, BH | 1 |
| Hudson, O | 1 |
| Hage, FG | 1 |
| Mah, D | 1 |
| Pournazari, P | 1 |
| Berman, DS | 1 |
2 reviews available for diphosphoric acid and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Radiopharmaceutical supply disruptions and the use of
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Diphosphonates; Humans; Prealbumin; Radiopharmaceutical | 2022 |
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Heart; Humans; Prealbumin; Radionucli | 2023 |
23 other studies available for diphosphoric acid and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Magnetic Resonance Spe | 2022 |
Volumetric evaluation of
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Prealbumin; Radiopharmaceuticals; Retrospective | 2022 |
Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Echocardiography; Humans; Prealbumin | 2023 |
The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Heart Failure; Humans; Natriuretic P | 2022 |
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis.
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Heart Failure; Humans; Prealbumin; Technetium | 2022 |
Topics: Amyloid Neuropathies, Familial; Biomarkers; Cardiomyopathies; Diphosphates; Humans; Muscle, Skeletal | 2023 |
[Myocardial scintigraphy with
Topics: Algorithms; Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Myocardial Perfusion Imaging; Radio | 2022 |
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Humans; Reproducibility of Results; | 2023 |
Comparison of 1-h with 3-h planar
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Kidney Diseases; Prealbumin; Radionuclide Imagi | 2023 |
Serial
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Diphosphates; Heart Failure; Humans; | 2023 |
Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Predictive Value of Tests; Radiopharmaceuticals | 2023 |
Microcalcification and
Topics: Amyloidosis; Calcinosis; Cardiomyopathies; Diphosphates; Humans; Immunoglobulin Light-chain Amyloido | 2023 |
Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
Topics: Aged; Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Prealbumin; Radiopharmaceuticals; Technet | 2023 |
Tafamidis Treatment Decreases
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Prealbumin; Pre | 2023 |
Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Follow-Up Studies; Humans; Prealbumin; Retrospective St | 2023 |
In the thick of it: hereditary cardiac amyloidosis identified by
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Magnetic Resonance Imaging; Positron-Emission T | 2023 |
Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Humans; Radionuclide Imaging; Radiop | 2023 |
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.
Topics: Aged; Amyloidosis; Cardiomyopathies; Diphosphates; Female; Humans; Male; Middle Aged; Prealbumin; Pr | 2023 |
Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy.
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Prealbumin; Rad | 2023 |
A case of disappearing amyloid on technetium pyrophosphate scan.
Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Humans; Prealbumin; Radionuclide Imaging; Radiopharmace | 2023 |
Hyperphosphatemia-Related False-Positive 99m Tc-Pyrophosphate Myocardial Scan: A Case Report With Endomyocardial Biopsy Result.
Topics: Biopsy; Cardiomyopathies; Diphosphates; Humans; Hyperphosphatemia; Prealbumin; Technetium; Technetiu | 2023 |
Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
Topics: Cardiomyopathies; Diphosphates; Heart; Humans; Prealbumin; Technetium Tc 99m Pyrophosphate; Tomograp | 2023 |
Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Female; Hum | 2021 |